Blog
Cancer Center at MEDICA 2018 Düsseldorf , November 12-15, 2018
We take part in MEDICA - the leading international trade fair for the medical sector in Düsseldorf / Germany from 12 - 15 November 2018. We present our new product for Pathologists and researchers: micro.cancercenter.ai [gallery link="file"...
Cancer Center at TechCrunch Disrupt 2018 San Francisco, September 5-7, 2018
This year’s TC Disrupt attracted some of the world’s top tech startups with the biggest influencers from Silicon Valley and other parts of the world! Featured guests included Uber CEO Dara Knosrowshahi, Greylock Partners’ Reid Hoffman, Bumble Founder & CEO...
Our paper at PubMed: The first MICCAI challenge on PET tumor segmentation
Abstract INTRODUCTION: Automatic functional volume segmentation in PET images is a challenge that has been addressed using a large array of methods. A major limitation for the field has been the lack of a benchmark dataset that would allow direct comparison of the...
Cancer Center on Pioneers.io in Vienna
We've been on Pioneers in Vienna on 24-25 April 2018.
We’re in nVidia Inception Program
We've just got the email from nVidia: "Congratulations! You’re in Inception. After careful review, we have determined Cancer Center is a great fit for NVIDIA’s Inception Program. Thank you for advancing the field of Artificial Intelligence (AI) in a meaningful way!"...
FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems
Good news! The U.S. Food and Drug Administration today permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes. Diabetic retinopathy occurs...